Estimates Revisions Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 2026-07-31			5-day change	1st Jan Change
2,710.00 ^MXN	-0.88%		+1.46%	+8.40%

08-02	Novartis' Pluvicto Gets US FDA Nod for Metastatic Prostate Cancer Treatment	MT
07-31	Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment For Pluvicto	DJ

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	ASTRAZENECA PLC
	NOVO NORDISK A/S
	AMGEN INC.
	GILEAD SCIENCES, INC.
	PFIZER INC.
	Average
	Weighted average by Cap.